Patents by Inventor Risto Tanner

Risto Tanner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240102930
    Abstract: This invention relates to a novel method and a device for quantitative concentration measurements of protein bound and middle sized uremic toxins and advanced glycation end-products in the biological fluids, preferably in the spent dialysate. Invention combines unique spectral ranges of fluorescence and absorption to determine concentration of uremic toxins, such as indoxyl sulphate, beta-2-microglobulin and 4-pyridoxic acid in a way that provides significantly higher precision than previously known solutions.
    Type: Application
    Filed: March 31, 2022
    Publication date: March 28, 2024
    Applicant: TALLINN UNIVERSITY OF TECHNOLOGY
    Inventors: Jurgen ARUND, Risto TANNER, Ivo FRIDOLIN, Joosep PAATS
  • Patent number: 9103789
    Abstract: This invention relates to a novel method and a device for determining middle and protein bound uremic toxins in the biological fluids. More specifically, the present invention relates to an optical method utilizing fluorescence, preferable fluorescence of the spent dialysate, and a specific model, including a unique set of optical spectral components at certain wavelengths, to determine, preferable on-line, the concentration of the middle and protein bound uremic toxins such as beta2-microglobulin (B2M), and indoxyl sulfate (IS).
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: August 11, 2015
    Assignee: TALLINN UNIVERSITY OF TECHNOLOGY
    Inventors: Ivo Fridolin, Fredrik Uhlin, Jana Holmar, Risto Tanner, Jurgen Arund
  • Publication number: 20130193347
    Abstract: This invention relates to a novel method and a device for determining middle and protein bound uremic toxins in the biological fluids. More specifically, the present invention relates to an optical method utilizing fluorescence, preferable fluorescence of the spent dialysate, and a specific model, including a unique set of optical spectral components at certain wavelengths, to determine, preferable on-line, the concentration of the middle and protein bound uremic toxins such as beta2-microglobulin (B2M), and indoxyl sulfate (IS).
    Type: Application
    Filed: June 28, 2011
    Publication date: August 1, 2013
    Applicant: Tallinn University of Technology
    Inventors: Ivo Fridolin, Fredrik Uhlin, Risto Tanner, Jurgen Arund
  • Patent number: 4640016
    Abstract: A remote indication compass, a sensor of which is formed by a magnetic compass (1) and magnetoresistive sensors (2) attached thereto, by means of which sensors the field created by the magnetic compass is measured. The signal of the sensors is analogous as well as cyclic with respect to the angle between the fastening plate of the sensors and the northern direction indicated by the magnetic compass, the length of a cycle being 360.degree.. The angle between the sensors is selected in such a manner that the flat areas of the signals do not coincide.The sensor signals are amplified and digitalized and scaled. The determination of direction is carried out by comparing the sensor readings to tabulated sensor readings corresponding to different directions or alternatively by comparing the ratio of the sensor readings to the ratios of the tabulated sensor readings. The direction data so obtained is further corrected by means of a deviation correction table created in the operating condition and stored in a memory.
    Type: Grant
    Filed: December 18, 1985
    Date of Patent: February 3, 1987
    Inventors: Risto Tanner, Hannu Purhonen